Distinct Healthcare Co Ltd (Ticker: 2677 HK) is a China-based private medical service provider specializing in the mid-to-high-end healthcare market. The company plans to list on the Main Board of the Hong Kong Stock Exchange (HKEX) on February 6, 2026. Distinct Healthcare intends to offer 4.75 million shares at a price range of HKD 57.70 to HKD 66.60 per share. If priced at the top of the range, the IPO is expected to raise up to HKD 316.35 million (approximately 40.5 million USD). At the proposed pricing, the company anticipates a market capitalization ranging from HKD 3.71 billion to HKD 4.29 billion (roughly 476 million to 549 million USD).

Operating a network of 19 institutions across major Chinese cities, including clinics and hospitals, and additional clinics in Singapore and Malaysia, Distinct Healthcare reportedly focuses on a "whole-family care" model integrating in-person and tele-healthcare services for the mass affluent population. Notable shareholders include Tencent Holdings and Tian Tu Capital. According to listing documents, the company plans to use the IPO proceeds for research and development, expanding product capacity, strategic acquisitions, and general working capital. SPDB International Capital and Haitong International Capital are acting as joint sponsors for the offering.